M4MM

New Zealand Approves Psilocybin for Medicinal Use

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...

Week In Review: Colorado Voter Initiative Challenges Federal Law on Cannabis Users’ Gun Rights: MedMen Reduces Operations to Four States with Sale of Arizona and Nevada Assets: Biden’s Groundbreaking Pardons Signal a Paradigm Shift in Cannabis Policy and Justice Reform:

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets: there’s innovation and progress in full swing in some parts of the country, while in other parts, ...

Curaleaf’s Corporate Strategy for U.S. Unit

New York-based Curaleaf Holdings is embarking on a strategic reorganization of its U.S. subsidiary, Curaleaf USA. This move is part of the company's broader plan to list on the Toronto Stock Exchange, reflecting a significant ...

Subscribe To Our Newsletter